This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Larry Bauer
Sr. Regulatory Drug Expert at Hyman, Phelps, & McNamara, P.C.


Larry Bauer is a Sr. Regulatory Drug Expert with Hyman, Phelps, & McNamara, P.C. and assists medical product industry and patient advocacy organization clients in a wide range of regulatory matters, including new drug and biologic development and approval issues. Prior to this position he worked at the FDA in CDER’s Rare Diseases Program working on policy, education, and science related to rare disease drug development. He has expertise in Rare Pediatric Disease priority review vouchers and designations, expedited programs, and patient engagement including extensive experience guiding patient advocacy groups. He also serves on the National Organization for Rare Disorders (NORD) Advocacy Committee.

Larry Bauer's Network

Agenda Sessions

  • Payer and Provider Transformation: a Deep Dive into Innovative and Evidence-Based Frameworks incorporating the Patient Voice